Study to Evaluate the Safety of Retreatment With Restylane® Lyft With Lidocaine for Augmentation of the Chin Region
Galderma R&D · NCT07566286
Opens the official ClinicalTrials.gov record, with the study team’s contacts. Bored Studies doesn’t enroll anyone.
Key facts
- Compensation
- Not posted. Ask the study team before screening.
- Who can join
- Ages 22+ · All sexes
- Healthy volunteers
- Accepted
- Study type
- Interventional · Not applicable
- Target enrollment
- 100
- US sites recruiting
- 7
- Study start
- June 3, 2026
- Record last updated
- August 14, 2026
Status re-checked against ClinicalTrials.gov within the last 12 hours.
What the study is about
The primary objective of this study is to evaluate the safety of Restylane Lyft with Lidocaine for augmentation of the chin region 3 months after retreatment.
Being studied: Restylane Lyft with Lidocaine
Conditions: Chin Augmentation
Eligibility criteria
Copied from the official record. The study team makes the final decision at screening.
Show full criteria
Inclusion Criteria
- Males or non-pregnant, non-breastfeeding females, 22 years of age or older.
- Intent to receive treatment for augmentation and correction of retrusion in the chin region.
Exclusion Criteria
- Known/previous allergy or hypersensitivity to any injectable hyaluronic acid (HA) gel or to gram positive bacterial proteins.
- Known/previous allergy or hypersensitivity to local anesthetics, e.g. lidocaine or other amide-type anesthetics.
- Previous or present multiple allergies or severe allergies, such as manifested by anaphylaxis or angioedema, or family history of these conditions.
- Previous facial surgery (including facial aesthetic surgery and liposuction), below the level of the horizontal line from subnasale.
- Any previous aesthetic procedures or implants.
- Presence of any disease or lesions near or on the area to be treated.
Recruiting US locations
Galderma Investigational Site # 8680
Westport, CT 06880
Site contact: Galderma Project Manager
Galderma Investigational Site # 8774
Boynton Beach, FL 33437
Site contact: Galderma Project Manager
Galderma Investigational Site # 7030
Coral Gables, FL 33134
Site contact: Galderma Project Manager
Galderma Investigational Site # 8682
Coral Gables, FL 33134
Site contact: Galderma Project Manager
Galderma Investigational Site # 7042
Atlanta, GA 30331
Site contact: Galderma Project Manager
Galderma Investigational Site # 7118
Nashville, TN 37203
Site contact: Galderma Project Manager
Galderma Investigational Site # 8662
Spring, TX 77388
Site contact: Galderma Project Manager
Study contacts (from the official record)
- Clinical Project Manager · 817-961-5000 · clinical.studies@galderma.com
Similar studies in Connecticut
All healthy volunteers studies in Connecticut →- RecruitingHealthy volunteersPhase 1Overnight stay mentioned
A Study to Learn How Different Amounts of the Study Medicine Called PF-08103402 Are Tolerated and Act in the Body in Healthy Adults or Adults With Mild To-moderate Asthma
Pfizer
- Location
- New Haven, CT
- Eligibility basics
- Ages 18–65
- RecruitingHealthy volunteersEarly Phase 1Overnight stay mentioned
Investigating the Mu:Kappa Opioid Receptor Imbalance in Alcohol Use Disorder
Yale University
- Location
- New Haven, CT
- Eligibility basics
- Ages 21–70
- RecruitingHealthy volunteersPhase 1
MK-0947 PN-002: An Open-label Study to Evaluate Brain α-synuclein Deposition Using Positron Emission Tomography (PET) and [¹⁸F]MK-0947 in Participants With Parkinson's Disease (PD)
XingImaging, LLC
- Location
- New Haven, CT
- Eligibility basics
- Ages 40–80
- RecruitingHealthy volunteersEarly Phase 1
A Study of the Pharmacokinetics, Biodistribution and Dosimetry of Granzyme-B Targeted [Cu-64]-Labeled PET Radiotracers in Adult Healthy Volunteers
Ratio Therapeutics, Inc.
- Location
- New Haven, CT
- Eligibility basics
- Ages 18–60